Clinical Trials in San Francisco

Showing 6881-6900 of 12,991 trials

Cysteamine Bitartrate Delayed-Release for the Treatment of NAFLD in Children

NCT01529268

CyNCh is a multi-center, placebo-controlled clinical trial of children ages 8 to 17 years with biopsy-confirmed moderate to severe nonalcoholic fatty liver disease (NAFLD). The primary objective is to evaluate whether 52 weeks of treatment with cysteamine bitartrate delayed-release capsules will result in improvement in liver disease severity.

Nonalcoholic Fatty Liver Disease (NAFLD)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)169 participantsStarted Jun 2012

San Diego, California, United States • San Francisco, California, United States • Atlanta, Georgia, United States +7 more locations

COMPLETEDPhase 3< 1 mile

Short Bowel Syndrome Research Study for Children Up To 17 Years of Age on Parenteral Nutrition

NCT02682381

Teduglutide is approved for treatment of adults with short bowel syndrome (SBS). The purpose of this study is to evaluate the safety and efficacy of teduglutide in children up to the age of 17 with SBS who are dependent on parenteral support. Subjects may choose whether to receive the study drug or to participate in a standard-of-care arm. All participants who complete the study may be eligible to receive the study drug in a long-term extension study.

Short Bowel Syndrome

Shire59 participantsStarted Jun 2016

Los Angeles, California, United States • Los Angeles, California, United States • San Francisco, California, United States +24 more locations

Cysteamine Bitartrate Delayed-Release for the Treatment of NAFLD in Children

Short Bowel Syndrome Research Study for Children Up To 17 Years of Age on Parenteral Nutrition

Find Trials by Condition in San Francisco

An Efficacy and Safety Study of SRM003 in the Treatment of Subjects Undergoing Creation of an Arteriovenous Fistula to Facilitate Hemodialysis Access

Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment

Extension of Study TKT024 Evaluating Long-Term Safety and Clinical Outcomes in MPS II Patients Receiving Idursulfase

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

A Study to Evaluate the Effect of Low Level Laser Light on Low Back Pain

An Efficacy and Safety Evaluation of HORIZANT in Adolescents With Moderate-to-Severe Primary RLS

Study of the Effects of Oxytocin on Attentional Bias and Startle in PTSD

CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial

Validation of an Artificial Intelligence-based Algorithm for Skeletal Age Assessment

Me-GC: A Randomized Controlled Trial of Meditation for Genetic Counselors

Safety and Efficacy Study of VP20621 for Prevention of Recurrent Clostridium Difficile Infection

A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3)

Study of Safety and Efficacy of a rhPTH[1-84] of Fixed Doses of 25 and 50 mcg in Adults With Hypoparathyroidism (RELAY)

A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis

Tilt-Table Study of the Clinical Efficacy of Midodrine in Symptomatic Orthostatic Hypotension

Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate

A Phase 2 Open-label Pilot Study Evaluating MYK-461 in Subjects With Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction

Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia